Nadir CA-125 serum levels during neoadjuvant chemotherapy and no residual tumor at interval debulking surgery predict prognosis in advanced stage ovarian cancer

BACKGROUND: Recent phase III randomized trials have suggested that neoadjuvant chemotherapy followed by interval debulking surgery (NACT-IDS) is a treatment option for patients with advanced epithelial ovarian cancer. This study aimed to use CA-125 and computed tomography (CT) scanning to generate a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World J Surg Oncol
Main Authors: Nakamura, Kazuto, Kitahara, Yoshikazu, Nishimura, Toshio, Yamashita, Soichi, Kigure, Keiko, Ito, Ikuro, Kanuma, Tatsuya
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7427056/
https://ncbi.nlm.nih.gov/pubmed/32791996
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-020-01978-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados